Chen Luo

841 total citations
39 papers, 553 citations indexed

About

Chen Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chen Luo has authored 39 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Chen Luo's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and Ferroptosis and cancer prognosis (5 papers). Chen Luo is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and Ferroptosis and cancer prognosis (5 papers). Chen Luo collaborates with scholars based in China. Chen Luo's co-authors include Jinfeng Zhu, Xiaojian Zhu, Lin Kang, Wenjun Zhang, Fanqin Bu, Zhengming Zhu, Chao Huang, Rongfa Yuan, Jiefeng Zhao and Jun Huang and has published in prestigious journals such as Frontiers in Immunology, Experimental Cell Research and European Journal of Pharmacology.

In The Last Decade

Chen Luo

37 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Luo China 15 319 202 103 97 65 39 553
Sun Mi Hong South Korea 13 391 1.2× 139 0.7× 115 1.1× 70 0.7× 115 1.8× 21 619
Sukjin Yang United States 11 523 1.6× 341 1.7× 108 1.0× 65 0.7× 84 1.3× 16 789
Cristina Nuevo‐Tapioles Spain 14 452 1.4× 196 1.0× 91 0.9× 63 0.6× 89 1.4× 23 664
Ruorong Yan China 8 586 1.8× 165 0.8× 149 1.4× 53 0.5× 40 0.6× 10 786
Maohui Feng China 14 343 1.1× 210 1.0× 150 1.5× 98 1.0× 58 0.9× 54 605
Yajie Xiong China 12 263 0.8× 169 0.8× 80 0.8× 48 0.5× 27 0.4× 17 412
Zhen Cai China 7 475 1.5× 149 0.7× 81 0.8× 48 0.5× 62 1.0× 9 593
Fenghua Lan China 15 384 1.2× 137 0.7× 110 1.1× 123 1.3× 59 0.9× 62 712
Jianling Xia China 13 369 1.2× 170 0.8× 133 1.3× 81 0.8× 41 0.6× 20 571

Countries citing papers authored by Chen Luo

Since Specialization
Citations

This map shows the geographic impact of Chen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Luo more than expected).

Fields of papers citing papers by Chen Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Luo. The network helps show where Chen Luo may publish in the future.

Co-authorship network of co-authors of Chen Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Luo. A scholar is included among the top collaborators of Chen Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Luo. Chen Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Chen, Rui Sun, Yuting Zhang, et al.. (2025). PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1. Frontiers in Immunology. 16. 1581398–1581398. 8 indexed citations
2.
Zhao, Jiali, et al.. (2024). Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis. Journal of Translational Medicine. 22(1). 1000–1000. 2 indexed citations
3.
4.
Luo, Chen, Yi Yu, Jinfeng Zhu, et al.. (2024). Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Cell & Bioscience. 14(1). 35–35. 6 indexed citations
5.
Li, Dan, et al.. (2023). MicroRNA 211-5p inhibits cancer cell proliferation and migration in pancreatic cancer by targeting BMP2. Aging. 15(23). 14411–14421. 4 indexed citations
6.
7.
Li, Huichang, et al.. (2022). Topological Refraction in Kagome Split-Ring Photonic Insulators. Nanomaterials. 12(9). 1493–1493. 5 indexed citations
8.
Zhu, Jinfeng, Qian Huang, Chen Luo, et al.. (2022). Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma. Frontiers in Oncology. 12. 799475–799475. 12 indexed citations
9.
Liu, Sicheng, Xun Wu, Fanqin Bu, et al.. (2022). Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer. World Journal of Surgical Oncology. 20(1). 71–71. 2 indexed citations
10.
Zhu, Jinfeng, Jiefeng Zhao, Chen Luo, et al.. (2022). FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Cell Death and Disease. 13(5). 497–497. 18 indexed citations
11.
Zhu, Jinfeng, Sicheng Liu, Chen Luo, et al.. (2022). Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma. Frontiers in Immunology. 13. 990790–990790. 30 indexed citations
12.
Luo, Chen, Lin Kang, Cegui Hu, et al.. (2021). LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Molecular Therapy — Nucleic Acids. 26. 523–535. 29 indexed citations
13.
Zhang, Wenjun, et al.. (2021). PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells. European Journal of Pharmacology. 899. 174041–174041. 46 indexed citations
14.
Zhang, Wenjun, et al.. (2021). Microencapsulated Neural Stem Cells Inhibit Sciatic Nerve Injury-Induced Pain by Reducing P2 × 4 Receptor Expression. Frontiers in Cell and Developmental Biology. 9. 656780–656780. 9 indexed citations
15.
Zhu, Jinfeng, Chen Luo, Jiefeng Zhao, et al.. (2021). Expression of LOX Suggests Poor Prognosis in Gastric Cancer. Frontiers in Medicine. 8. 718986–718986. 29 indexed citations
16.
Bu, Fanqin, Xiaojian Zhu, Xuan Yi, et al.. (2020). <p>Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients</p>. OncoTargets and Therapy. Volume 13. 11433–11444. 22 indexed citations
17.
Zhang, Wenjun, et al.. (2020). The role and pharmacological characteristics of ATP-gated ionotropic receptor P2X in cancer pain. Pharmacological Research. 161. 105106–105106. 27 indexed citations
18.
Li, Qing, Leifeng Chen, Chen Luo, et al.. (2020). TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth. Experimental Cell Research. 391(1). 111975–111975. 12 indexed citations
19.
Luo, Chen, et al.. (2019). Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway. Cancer Cell International. 19(1). 314–314. 14 indexed citations
20.
Zheng, Chao, et al.. (2018). miRNA-185 regulates the VEGFA signaling pathway in dairy cows with retained fetal membranes. Theriogenology. 110. 116–121. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Mi Hong Breakdown of academic impact, for papers by Sukjin Yang Breakdown of academic impact, for papers by Cristina Nuevo‐Tapioles Breakdown of academic impact, for papers by Ruorong Yan Breakdown of academic impact, for papers by Maohui Feng Breakdown of academic impact, for papers by Yajie Xiong Breakdown of academic impact, for papers by Zhen Cai Breakdown of academic impact, for papers by Fenghua Lan Breakdown of academic impact, for papers by Jianling Xia
Rankless by CCL
2026